Advertisement
Advertisement

RAPP

RAPP logo

Rapport Therapeutics, Inc. Common Stock

38.08
USD
Sponsored
+0.84
+2.26%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

38.05

-0.03
-0.08%

Rapport Therapeutics, Inc. Common Stock Profile

About

Rapport Therapeutics Inc. is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc. is based in BOSTON.

Info & Links

CEO

Abraham N. Ceesay

Headquarters

99 HIGH STREET, SUITE 2100
BOSTON, MA 02110, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.rapportrx.com

Auditor

PricewaterhouseCoopers LLP

Share holders

37

Employees

84

Rapport Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.82B

Enterprise Value

1.77B

Enterprise Value/EBITDA(ttm)

-14.08

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.37

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-28.85%

Return on Invested Capital(ttm)

-30.79%

Return on Assets(ttm)

-27.27%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-125.48M

Net Income Available to Common(ttm)

-111.48M

Diluted EPS(ttm)

-2.86

Share Statistics

Beta (5Y Monthly)

1.09

52-Week Change

281.18%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

47.79M

Dividend Yield

0.00%

Float4

41.31M

% Held by Insiders

13.57%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

490.64M

Total Cash Per Share(mrq)

10.27

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

26.17%

Quick Ratio(mrq)

26.17%

Book Value Per Share(mrq)

10.14

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.25

Free Cash Flow(ytd)

-88.09M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement